IRME · IR-Med, Inc.
Market Cap
$162,201
Shares
77.24M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Net Income
-$1.9M
+61.3%
FY2024
Diluted EPS
-$0.03
+57.1%
FY2024
Operating Cash Flow
-$1.39M
+57.1%
FY2024
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| — | -$3000 | $20K | -$6000 | — | — | |
| $535K | $710K | $2.06M | $1.89M | $1.42M | $409K | |
| $902K | $1.01M | $2.03M | $2.12M | $1.37M | $321K | |
| -$1.46M | -$1.94M | -$4.91M | -$4.76M | -$3.68M | -$730K | |
| -$415K | -$6000 | $2000 | $28K | -$41K | -$22K | |
| — | $1.9M | $4.91M | $4.73M | $3.72M | -$752K | |
| -$2.35M | -$1.9M | -$4.91M | -$4.73M | -$3.72M | -$752K | |
| USD/shares | -$0.03 | -$0.03 | -$0.07 | -$0.07 | -$0.06 | — |
| USD/shares | -$0.03 | -$0.03 | -$0.07 | -$0.07 | — | — |
| shares | — | — | 69.4M | 67.58M | 63.11M | 30.03M |
| shares | — | 70.47M | 69.4M | 67.58M | — | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 41 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.